How Often do Level III Nodes Bear Melanoma Metastases and does it Affect Patient Outcomes?
Carolyn Nessim(University of Ottawa), Frances C. Wright(Saint John's Health Center), Calvin Law(Sunnybrook Health Science Centre), Gregory McKinnon(Saint John's Health Center), Yarrow J. McConnell(Alberta Health Services)
Cited by 15
Related Papers
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group
|Annals of Surgical Oncology|2021|251
Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG
|Clinical Cancer Research|2019|116
Dual inhibition of Wnt and Yes‐associated protein signaling retards the growth of triple‐negative breast cancer in both mesenchymal and epithelial states
|Molecular Oncology|2018|75
Radioactive Seed Localization Versus Wire-Guided Localization for Nonpalpable Breast Cancer: A Cost and Operating Room Efficiency Analysis
|Annals of Surgical Oncology|2017|70